Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
210 participants
INTERVENTIONAL
2009-10-31
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaccination for Middle Ear Infection
NCT00001605
Acute Otitis Media: Adjuvant Therapy to Improve Outcome
NCT00000363
Study to Compare Efficacy and Safety of AR01 to a Placebo Solution for Relief of Pain in Acute Otitis Media (AR01007)
NCT02074007
Does Tympanometry Predict Antibiotic Usage in Acute Otitis Media?
NCT01941381
The Efficacy of Nasal Steroids in Treatment of Otitis Media With Effusion: Acomparative Study
NCT03491098
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Homeopathic ear drops
Commercially available homeopathic ear drops
Hyland's earache drops
3-4 drops in affected ear 3 times a day as needed for up to 5 days
standard therapy
standard therapy for otitis media, no ear drops
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hyland's earache drops
3-4 drops in affected ear 3 times a day as needed for up to 5 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosed with otitis media by clinician at participating clinic
* Clinician determines that a "watch and wait" antibiotic prescription treatment plan is optimal management
Exclusion Criteria
* Homeopathic treatment within past 30 days
* History of serious chronic illness (e.g. diabetes, autoimmune disease, cystic fibrosis
* Perforated tympanic membrane
* Immediate antibiotic treatment plan decided by examining clinician
6 Months
11 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Washington
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
James Taylor
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
James A Taylor, MD
Role: PRINCIPAL_INVESTIGATOR
University of Washington
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mercer Island Pediatric Associates
Mercer Island, Washington, United States
Valley Children's Clinic
Renton, Washington, United States
University of Washington Medical Center-Roosevelt Pediatric Care Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
37011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.